Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XcelerateXCRT -2.36% Days Payable is 391.36 as of Sep. 2025, which is 402% above its 10-year median of 78.02. The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Xcelerate ranks better than 95.37% on this metric.
Xcelerate's average Accounts Payable for the
three
months ended in Sep. 2025 was $1.35 Mil. Xcelerate's Cost of Goods Sold for the
three
months ended in Sep. 2025 was $0.32 Mil.
Hence, Xcelerate's Days Payable for the
three
months ended in Sep. 2025 was 391.36.
The historical rank and industry rank for Xcelerate's Days Payable or its related term are showing as below:
XCRT'
s Days Payable Range Over the Past 10 Years
Min: 41.24 Med: 78.02 Max: 645.44
Current: 645.44
During the past 7 years, Xcelerate's highest Days Payable was 645.44. The lowest was 41.24. And the median was 78.02.
XCRT's Days Payable is ranked better than 95.37% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 57.08
vs XCRT: 645.44
Xcelerate's Days Payable
increased
from Sep. 2008 (138.89) to Sep. 2025 (391.36).
It may suggest that Xceleratedelayed paying its suppliers.
The historical data trend for Xcelerate's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Xcelerate's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xcelerate Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Xcelerate's Days Payable distribution charts can be found below:
* The bar in red indicates where Xcelerate's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Xcelerate's Days Payable for the fiscal year that ended in Dec. 2007 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xcelerate (XCRT) has a Days Payable of 391.36 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xcelerate and its competitors. This is 402% above median its historical median of 78.02. Over the past decade, Xcelerate's Days Payable has ranged from 41.24 to 645.44. According to the industry distribution chart, Xcelerate ranks #28 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 4.6%.
Is Xcelerate's Days Payable too high?
Xcelerate's current Days Payable of 391.36 is 402% above median its 10-year median of 78.02. Over the past 10 years, this metric has ranged from a low of 41.24 to a high of 645.44. The Healthcare Providers & Services industry median Days Payable is 57.08. Xcelerate's value of 391.36 is 585.6% above this industry median. Based on the distribution chart, Xcelerate ranks #28 out of 605 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Xcelerate's Days Payable compare to RHEP and NIVF?
According to the Healthcare Providers & Services industry distribution chart, Xcelerate ranks #28 out of 605 companies for Days Payable. This places Xcelerate in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 57.08. Xcelerate's value of 391.36 is 585.6% above this benchmark. Historically, Xcelerate's own Days Payable has ranged from 41.24 to 645.44 over the past decade. While the company's 10-year median is 78.02 vs. the industry median of 57.08, Xcelerate has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.08, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xcelerate's current Days Payable of 391.36 is 585.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xcelerate and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xcelerate's current Days Payable is 391.36, which is 402% above median its own 10-year median of 78.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xcelerate stock overvalued right now?
Xcelerate (XCRT) has a current Days Payable of 391.36. The current Days Payable is 391.36, which is 402% above median its 10-year median of 78.02 and 585.6% above the Healthcare Providers & Services industry median of 57.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Xcelerate (XCRT), the current Days Payable is 391.36 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Xcelerate Inc is a healthcare services and products company engaged in three separate but related businesses within the medical, health, and wellness sectors. It is focused on the development of medical technology and the provision of virtual health services to help patients in developing countries meet their medical needs by extending the reach of physicians through technology. The company is also involved in the formulation, packaging, and marketing of consumer health and beauty, clinically tested skin and hair care products, and owns and licenses the rights to various forms of medical equipment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCRT has been successfully added to your 
